Ru Yan - Sun Yat-sen University Cancer Center

基本信息

浏览量：10

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 9 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Neoadjuvant Toripalimab Plus Nimotuzumab Combined with Taxol-Based Chemotherapy in Locally Advanced Penile Squamous Cell Carcinoma

Xin An,Sheng Jie Guo,Ru Yan,Ting Xue,Long Bin Xiong, Hua Li Ma,Cong Xue, Ying Chun Zhang,Ji Bin Li, Mei Ting Chen,Zai Shang Li,Ting Yu Liu,Zhi Ling Zhang,Pei Dong,Yong Hong Li,Kai Yao,Zhi Quan Hu, Xiao Feng Chen, Jie Xin Luo,Yong Hong Lei,Pei Yu Liang,Zhi Zhong Liu,Lin Qi, Wen Feng Xu, Zheng Guo Cao,Nan Hui Chen,Xiang Li,Xi Nan Sheng,Guang Heng Luo,Ben Kang Shi,Qun Xie,Zhuo Wei Liu,Fang Jian Zhou, Philippe E Spiess,Yan Xia Shi,Hui Han

Cancer cellno. 5 (2025): 970-980.e3

引用0浏览0WOS引用

First-Line PD-1 Blockade Combined with Chemotherapy for Stage IV Penile Squamous Cell Carcinoma: A Multicenter Retrospective Study

Longbin Xiong, Xingli Shan, Huali Ma,Shengjie Guo,Jiyan Liu, Xianda Chen,Wenjun Meng, Bin Guo,Lijuan Jiang,Ru Yan,Xin An,Yanxia Shi,Yijun Zhang,Ting Xue,Lichao Wei, Daming Xu,Zhiling Zhang,Zike Qin,Kai Yao, Yajian Li,Philippe E Spiess,Linjun Hu,Nianzeng Xing,Hui Han

Journal of the National Comprehensive Cancer Network JNCCNno. 1 (2024)

引用0浏览0WOS引用

Nilotinib in Combination with Sunitinib Renders MCL-1 for Degradation and Activates Autophagy That Overcomes Sunitinib Resistance in Renal Cell Carcinoma

Tingyu Liu,Xin Yue, Xue Chen,Ru Yan,Chong Wu,Yunzhi Li,Xianzhang Bu,Hui Han,Ran-Yi Liu

CELLULAR ONCOLOGYno. 4 (2024): 1277-1294

引用1浏览0WOS引用

Prognostic Significance and Immune Correlates of FADD in Penile Squamous Cell Carcinoma

Ting Xue,Ru Yan,Zaishang Li,Shengjie Guo, Xiao,Jietian Jin,Lijuan Jiang,Huali Ma,Chong Wu,Tingyu Liu,Lichao Wei,Longbin Xiong,Fangjian Zhou,Kai Yao,Ranyi Liu,Hui Han

VIRCHOWS ARCHIVno. 5 (2023): 869-878

引用1浏览0WOS引用

MP33-07 ANTI-PROGRAMMED DEATH RECEPTOR 1 PLUS ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODIES AND COMBINATION CHEMOTHERAPY FOR RELAPSED LOCALLY ADVANCED AND/OR METASTATIC PENILE SQUAMOUS CELL CARCINOMA

Longbin Xiong,Lichao Wei,Ting Xue,Ru Yan,Tingyu Liu,Lijuan Jiang,Huali Ma,Yanxia Shi,Xin An,Yijun Zhang,Shengjie Guo,Kai Yao,Fangjian Zhou,Hui Han

Journal of Urologyno. Supplement 4 (2023)

引用0浏览0引用

ANTI-PROGRAMMED DEATH RECEPTOR 1 PLUS ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODIES AND COMBINATION CHEMOTHERAPY FOR RELAPSED LOCALLY ADVANCED AND/OR METASTATIC PENILE SQUAMOUS CELL CARCINOMA

Longbin Xiong,Lichao Wei,Ting Xue,Ru Yan,Tingyu Liu,Lijuan Jiang,Huali Ma,Yanxia Shi,Xin An,Yijun Zhang,Shengjie Guo,Kai Yao,Fangjian Zhou,Hui Han

JOURNAL OF UROLOGY (2023): E452-E452

引用0浏览0引用

Anti-EGFR Antibody Plus Anti-Pd-1 Antibody and Chemotherapy As a Neoadjuvant Regimen for Patients with Locally-Advanced Penile Squamous Cell Carcinoma: A Prospective, Single-Arm, Single-Center, Phase II Clinical Trial

Xin An,Ru Yan,Shengjie Guo,Ting Xue,Huali Ma,Meiting Chen,Fangjian Zhou,Kai Yao,Pei Dong,Zhiling Zhang,Zhuowei Liu,Yanxia Shi,Hui Han

Journal of clinical oncology（2022）

引用0浏览0引用

First-line Programmed Death Receptor-1 (PD-1) Inhibitor and Epidermal Growth Factor Receptor (EGFR) Blockade, Combined with Platinum-Based Chemotherapy, for Stage IV Penile Cancer

Ru Yan,Huali Ma,Lijuan Jiang,Shengjie Guo,Yanxia Shi,Xinan Sheng,Yijun Zhang,Philippe E. Spiess,Tingyu Liu,Ting Xue,Xiaofeng Chen,Zhiyong Li,Xin An,Kai Yao,Fangjian Zhou,Hui Han

BJU International（2022）

引用11浏览0WOS引用

Immune Checkpoint Inhibitor Plus Anti-Egfr Target Therapy Plus Chemotherapy in Patients with Locally Advanced Penile Squamous Cell Carcinoma

Hui Han,Xin An,Ru Yan,Shengjie Guo,Cong Xue,Tingyu Liu,Li Tian,Huali Ma,Yonghong Li,Zike Qin,Zhuowei Liu,Fang-Jian Zhou,Yanxia Shi

Journal of Clinical Oncology（2021）

引用2浏览0引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn